CN104975104A - 阿尔茨海默病诊治标志物及其应用 - Google Patents
阿尔茨海默病诊治标志物及其应用 Download PDFInfo
- Publication number
- CN104975104A CN104975104A CN201510463468.9A CN201510463468A CN104975104A CN 104975104 A CN104975104 A CN 104975104A CN 201510463468 A CN201510463468 A CN 201510463468A CN 104975104 A CN104975104 A CN 104975104A
- Authority
- CN
- China
- Prior art keywords
- copg1
- gene
- disease
- alzheimer
- chip
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- A61K48/005—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'active' part of the composition delivered, i.e. the nucleic acid delivered
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
- G01N2800/2814—Dementia; Cognitive disorders
- G01N2800/2821—Alzheimer
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Public Health (AREA)
- Analytical Chemistry (AREA)
- Biomedical Technology (AREA)
- Veterinary Medicine (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biochemistry (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Pathology (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Physics & Mathematics (AREA)
- General Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Cell Biology (AREA)
- Marine Sciences & Fisheries (AREA)
- Gastroenterology & Hepatology (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
试剂 | 体积 |
正向引物 | 1μl |
反向引物 | 1μl |
SYBR Green聚合酶链式反应体系 | 12.5μl |
模板 | 2μl |
去离子水 | 补足25μl |
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510463468.9A CN104975104B (zh) | 2015-07-31 | 2015-07-31 | 阿尔茨海默病诊治标志物及其应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510463468.9A CN104975104B (zh) | 2015-07-31 | 2015-07-31 | 阿尔茨海默病诊治标志物及其应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104975104A true CN104975104A (zh) | 2015-10-14 |
CN104975104B CN104975104B (zh) | 2018-06-19 |
Family
ID=54272066
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510463468.9A Active CN104975104B (zh) | 2015-07-31 | 2015-07-31 | 阿尔茨海默病诊治标志物及其应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104975104B (zh) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105353135A (zh) * | 2015-11-23 | 2016-02-24 | 中国人民解放军第三军医大学第一附属医院 | 阿尔茨海默病标志物的用途 |
CN108048554A (zh) * | 2017-12-29 | 2018-05-18 | 北京泱深生物信息技术有限公司 | Thbd基因作为帕金森症诊断的分子标志物 |
CN109182513A (zh) * | 2018-11-27 | 2019-01-11 | 北京泱深生物信息技术有限公司 | 生物标志物scfd2在阿尔茨海默诊治中的应用 |
CN109593843A (zh) * | 2018-12-28 | 2019-04-09 | 北京泱深生物信息技术有限公司 | 生物标志物klhl35在阿尔茨海默诊治中的应用 |
CN117210549A (zh) * | 2023-08-29 | 2023-12-12 | 河络新图生物科技(上海)有限公司 | 检测人atp5d、cd69和cxcr4基因的物质及其应用 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009086306A1 (en) * | 2007-12-21 | 2009-07-09 | Whitehead Institute For Biomedical Research | Modulators of alpha-synuclein toxicity |
WO2011012672A1 (en) * | 2009-07-29 | 2011-02-03 | Pharnext | New diagnostic tools for alzheimer disease |
CN102174099A (zh) * | 2011-01-28 | 2011-09-07 | 河北农业大学 | 一种阿尔茨海默症的靶位蛋白质及其编码基因和应用 |
-
2015
- 2015-07-31 CN CN201510463468.9A patent/CN104975104B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009086306A1 (en) * | 2007-12-21 | 2009-07-09 | Whitehead Institute For Biomedical Research | Modulators of alpha-synuclein toxicity |
WO2011012672A1 (en) * | 2009-07-29 | 2011-02-03 | Pharnext | New diagnostic tools for alzheimer disease |
CN102174099A (zh) * | 2011-01-28 | 2011-09-07 | 河北农业大学 | 一种阿尔茨海默症的靶位蛋白质及其编码基因和应用 |
Non-Patent Citations (2)
Title |
---|
ALEXANDRA SELIVANOVA等: "COPI-mediated retrograde transport is required for efficient c-secretase cleavage of the amyloid precursor protein", 《BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS》 * |
张玉芳等: "Soat1基因的e-QTL定位和遗传调控网络分析", 《江苏医药》 * |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105353135A (zh) * | 2015-11-23 | 2016-02-24 | 中国人民解放军第三军医大学第一附属医院 | 阿尔茨海默病标志物的用途 |
CN108048554A (zh) * | 2017-12-29 | 2018-05-18 | 北京泱深生物信息技术有限公司 | Thbd基因作为帕金森症诊断的分子标志物 |
CN109182513A (zh) * | 2018-11-27 | 2019-01-11 | 北京泱深生物信息技术有限公司 | 生物标志物scfd2在阿尔茨海默诊治中的应用 |
CN109182513B (zh) * | 2018-11-27 | 2020-12-25 | 青岛泱深生物医药有限公司 | 生物标志物scfd2在阿尔茨海默诊治中的应用 |
CN109593843A (zh) * | 2018-12-28 | 2019-04-09 | 北京泱深生物信息技术有限公司 | 生物标志物klhl35在阿尔茨海默诊治中的应用 |
CN109593843B (zh) * | 2018-12-28 | 2021-08-13 | 青岛泱深生物医药有限公司 | 生物标志物klhl35在阿尔茨海默诊治中的应用 |
CN117210549A (zh) * | 2023-08-29 | 2023-12-12 | 河络新图生物科技(上海)有限公司 | 检测人atp5d、cd69和cxcr4基因的物质及其应用 |
Also Published As
Publication number | Publication date |
---|---|
CN104975104B (zh) | 2018-06-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104975104A (zh) | 阿尔茨海默病诊治标志物及其应用 | |
CN105567861A (zh) | Ifi27作为冠心病诊断标志物的用途 | |
CN108504658A (zh) | Linc01836在制备胃癌诊断产品、治疗药物中的用途 | |
CN105296656A (zh) | 一种诊治鼻咽癌的分子标志物 | |
CN105132575A (zh) | 骨质疏松症的分子标志物及其应用 | |
CN107475386B (zh) | 用于诊治骨肉瘤的长链非编码rna标志物 | |
CN105112550B (zh) | 作为骨质疏松症诊治靶标的mtus1基因 | |
CN105400885A (zh) | Tff2基因作为颅内动脉瘤诊治标志物的用途 | |
CN105296623A (zh) | 一种诊治骨关节炎的分子标志物 | |
CN104962657B (zh) | Yap1基因在阿尔茨海默病诊治中的应用 | |
CN105238872A (zh) | 检测caln1基因表达的产品在胆管癌诊治中的应用 | |
CN105400888A (zh) | 一种诊治颅内动脉瘤的分子标志物 | |
CN104878104A (zh) | 胆管癌诊治分子标志物及其应用 | |
CN105400894A (zh) | 椎间盘退行性病变诊治标志物 | |
CN105002172A (zh) | 检测eapp基因表达的试剂在诊治阿尔茨海默病中的应用 | |
CN105018484B (zh) | Crtap基因及其表达产物作为阿尔茨海默病的诊治靶标 | |
CN105087821B (zh) | 一种诊治骨质疏松症的分子标志物 | |
CN105154540B (zh) | Paep基因及其表达产物作为骨关节炎的诊治靶标 | |
CN105296657B (zh) | 颅内动脉瘤诊治标志物 | |
CN108034713A (zh) | 绝经后骨质疏松症诊疗靶点及其应用 | |
CN108048554A (zh) | Thbd基因作为帕金森症诊断的分子标志物 | |
CN105506169A (zh) | 子宫肌瘤诊治标志物 | |
CN104789689A (zh) | 作为肺腺癌诊治靶标的clec9a基因 | |
CN101784674A (zh) | Egfr抑制剂治疗的预测性标记物 | |
CN105603116B (zh) | 一种诊治子宫肌瘤的分子标志物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Alzheimer disease diagnosis and treatment marker and application thereof Effective date of registration: 20181225 Granted publication date: 20180619 Pledgee: Huaxia Bank Beijing branch Wanliu Limited by Share Ltd Pledgor: Beijing Yang Shen biology information technology company limited Registration number: 2018990001252 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20191206 Granted publication date: 20180619 Pledgee: Huaxia Bank Beijing branch Wanliu Limited by Share Ltd Pledgor: Beijing Yang Shen biology information technology company limited Registration number: 2018990001252 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20191225 Address after: Room 2503, Qianshan building, building D2, Qingdao International Innovation Park Phase II, No. 1, Keyuan Weiyi Road, Laoshan District, Qingdao, Shandong Province Patentee after: Qingdao Yangshen biomedical Co., Ltd Address before: 100080 Beijing city Haidian District Shanyuan Street No. 1 cubic court building room 3103 Patentee before: Beijing Yang Shen biology information technology company limited |
|
TR01 | Transfer of patent right |